about
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapyMicroRNAs in immune regulation--opportunities for cancer immunotherapyPoly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent mannersInduction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcelluloInduction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.MicroRNAs and STAT interplay.Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of gliomaSingle-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomasPremetastatic soil and prevention of breast cancer brain metastasisPrioritization schema for immunotherapy clinical trials in glioblastoma.Immunotherapeutic approaches for gliomaSystemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccinesMyeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development.Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice.Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomasExpression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.Detection of inflammatory cell function using (13)C magnetic resonance spectroscopy of hyperpolarized [6-(13)C]-arginine.Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody
P50
Q21245464-583DAE8F-0696-4990-AFAB-980CF600376DQ24631617-F0A67AED-EB0F-4C3C-8B7E-2A2A6F277AFDQ33945653-25B4759F-55D5-45AF-AAC3-9AE60171D739Q34666875-BE6CB9C5-E43B-44D1-BB41-AE346E977EDAQ34979511-A48CD54C-DF3B-4771-9DA2-69742F4635CEQ34986356-4630A7B9-6BD8-4199-B13C-EDD490605E22Q35163556-9FB234DE-8CAB-40EB-BCD3-808E3BF9597EQ35785559-6767A3CA-4A89-4391-B982-91C874EF06C2Q36057502-C806AE3F-2740-46F3-B61C-A3DA91987686Q36204396-526B738D-CC05-4F74-890D-1D21EEAC9E4CQ36943888-55B70215-2D95-4B1B-A8B4-A5C93F8EE129Q37078999-AB6A884E-EBCB-4A7B-B201-A41DF28DCF9FQ37267793-656EA1FD-ED13-4793-BA92-8F2CDD62D1A5Q37438563-95E91168-E2A5-4330-8A07-D4A9FFA5E4EEQ38047053-8A0C4B43-D51E-445C-AAB8-D66646DE191BQ38823584-5A72D5A2-CE18-404D-A1E2-2E243E0B5236Q40449390-7FF0B7C5-AE7B-45AD-8466-277581EAB838Q40582859-4EDC9B1C-8DF1-44F3-8726-D5A20D167983Q41870476-C2D9508C-9AF9-4752-9AE8-755F6BC0DB7AQ42368949-92648259-40E9-4D2B-8B13-45C73365C901Q43115465-F359F735-91F6-4B56-986C-AE315F6CC9FFQ46512368-C59F9445-2E3A-4935-A521-ED86A9B92DBAQ90141422-138DE818-192B-4656-935D-9F4B46D79E96
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gary Kohanbash
@ast
Gary Kohanbash
@en
Gary Kohanbash
@es
Gary Kohanbash
@nl
type
label
Gary Kohanbash
@ast
Gary Kohanbash
@en
Gary Kohanbash
@es
Gary Kohanbash
@nl
prefLabel
Gary Kohanbash
@ast
Gary Kohanbash
@en
Gary Kohanbash
@es
Gary Kohanbash
@nl
P106
P1153
23767971800
P31
P496
0000-0002-3953-8022